Interventions for Weight Gain in Adults Treated With Novel Antipsychotics

AUTOR(ES)

Aquila, Ralph

FONTE

Physicians Postgraduate Press

RESUMO

Background: Weight gain is a significant side effect associated with typical and atypical antipsychotic agents. It has the potential to add to the increased morbidity and mortality associated with schizophrenia and schizoaffective disorder. Because the newer antipsychotic medications have proved to be superior to traditional agents in controlling the positive and negative symptoms of schizophrenia, it is additionally critical to address the relationship of these newer agents to weight gain.

Documentos Relacionados

• Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia
• Are atypical antipsychotics associated with an increased risk of diabetes, and is this associated with weight gain?
• Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus
• Recent evidence and potential mechanisms underlying weight gain and insulin resistance due to atypical antipsychotics
• Body weight and weight gain related to pulmonary function decline in adults: a six year follow up study.